TIS 0.00% 0.0¢ tissue therapies limited

back of envelope calculations, page-11

  1. 11,047 Posts.
    lightbulb Created with Sketch. 3711
    Or alternatively, using the methodology that says be acquired at somewhere between 3 and 5 times sales (see post re competitor being acquired just prior to IPO) and
    using thymus number of sales @ $1.7B
    yields takeover value at between $5B-$8B
    divided by 170M shares to give
    Stock Price of between $29 - $47

    Clearly I must be dreaming!

    Using just 5% of the company target market size of $14B is still $700M with multiple at $2.1B - $3.5B

    Are we in that good a position???
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.